Why the study?
Does a multivariate combination of autonomic tests improve the diagnosis of diabetic autonomic neuropathy compared to individual tests in patients with Type-1 diabetes?
Case-Control (n=34)
Does a multivariate combination of autonomic tests improve the diagnosis of diabetic autonomic neuropathy compared to individual tests in patients with Type-1 diabetes?
A multivariate approach combining heart rate variation during deep breathing and pancreatic polypeptide response to hypoglycemia optimally separates patients with diabetic autonomic neuropathy from healthy controls.
May aid diabetic autonomic neuropathy diagnosis; hypothesis-generating and requires prospective validation before clinical use.
AIM/HYPOTHESIS: In the diagnosis of diabetic autonomic neuropathy (DAN) various autonomic tests are used. We took a novel statistical approach to find a combination of autonomic tests that best separates normal controls from patients with DAN. METHODS: Twenty-four patients with Type-1 diabetes mellitus considered as having mild to moderate DAN as well as 10 normal, nondiabetic control subjects were analysed, searching for a test or a combination of tests that would optimally discriminate Type-1 diabetes mellitus from controls. Variations of heart rate during deep breathing (deltaR6) and during a Valsalva manoeuvre (VR), the number of reactive sweat glands on the foot (testing sympathetic sudomotor function), and the response of human pancreatic polypeptide to hypoglycaemia [ln(deltahPP+1)] were evaluated. RESULTS: Respective values for respective sensitivity and specificity values were: deltaR6, 96 and 70%; VR, 96 and 60%; sweat gland function, 71 and 90%; and ln(deltahPP+1), 71 and 90%. In a multivariate analysis approach a single discriminant function separating patients with Type-1 diabetes mellitus from nondiabetic controls was generated [Logit P=288.5-[14.7 deltaR6]-[26.6 ln(deltahPP+1)]]. This function allowed complete separation of patients with Type-1 diabetes mellitus from normal controls. CONCLUSION/INTERPRETATION: We conclude that the combined determination of deltaR6 and of ln (deltahPP+1) optimally separates subjects with parasympathetic impairment from normal subjects. In addition, this combination of tests may serve as a sensitive method for the assessment of DAN.
No takes yet. Share an insight, caveat, or question.
Diem et al. (2003) conducted a case-control in Diabetic autonomic neuropathy (n=34). Combined determination of deltaR6 and ln(deltahPP+1) vs. Individual autonomic tests was evaluated on Separation of patients with Type-1 diabetes mellitus from normal controls.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: